Abstract: Background: Knee proprioception is essential for injury prevention, stability, and performance improvement. Reliable proprioception measurement tools are crucial for accurate assessment and ...
Objectives To systematically review the scientific literature regarding the acute assessment of sport-related concussion (SRC) and provide recommendations for improving the Sport Concussion Assessment ...
Google told us this is a "minor update to our rater guidelines with small clarifications and a handful of new examples." Google has pushed a minor update to its search quality raters guidelines PDF ...
Smartphones are durable, powerful devices we carry everywhere. They get slightly better every year, too. Whether that's through improved glass technology that's more shatter- and scratch-proof, or ...
Sigmoid colon biopsy from a patient with treated ulcerative colitis showing chronic inflammation in the lamina propria and a focal area (black arrow in a) with intraepithelial and lamina propria ...
In a cross-sectional study, the Ichthyosis Scoring System (ISS) demonstrated equal reliability in assessing scale and erythema severity across all skin types, with excellent interrater reliability for ...
A recent study published in Housing Policy Debate, “Assessing the Reliability of SPDAT Homelessness Vulnerability Tools and the Impact of Assessor Consistency and Changes to Homeless Vulnerability ...
Objective To identify functional performance tests (FPTs) with potential to identify athletes at risk of lower extremity injury (LEI) and assess their measurement properties. Design Systematic review ...
A literature review has confirmed that the Eczema Area and Severity Index (EASI) is an effective tool for measuring the severity and extent of atopic dermatitis (AD) -- including in patients with more ...
Please provide your email address to receive an email when new articles are posted on . Results showed high to very high relative reliability among patients. Interrater reliability had wider value ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback